CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-07-24). The draft was written by AI, the existence of all 2 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 1885 · Search date 2026-07-24 · Methodology v0.6

Powered toothbrush,
does it really help with Improved gingivitis and gingival-bleeding indices versus a manual toothbrush?

30-Second Summary
C
Evidence Grade C · 52 · Safety acceptable
Powered brushes modestly improve gingivitis and bleeding indices, but long-term clinical importance remains uncertain
Reported harms were mainly transient gingival abrasion or soft-tissue irritation. Excess pressure or poor technique can injure gums, so soft bristles and pressure control matter.
What the
research shows
Powered toothbrushes earn C with 52 points because they produce a small gingivitis-index improvement of unclear clinical importance. The review included 56 trials and 5,068 participants, with 51 trials suitable for meta-analysis; the beyond-three-month estimate, SMD -0.21 (95% CI -0.31 to -0.12), came from 16 trials and 1,645 participants, I-squared 51%.
What the
ads claim
The evidence does not show that a powered brush treats periodontitis or prevents tooth loss. It shows a modest average improvement in gingivitis and bleeding indices.
*

Useful facts when choosing a product

  • The review included 56 trials and 5,068 participants, and 51 trials were suitable for meta-analysis.
  • The beyond-three-month estimate came from 16 trials and 1,645 participants.
  • Funding was manufacturer support in 37 trials, a government scholarship in one, and unclear in 18.
Gap Measurement · Verdict 1885 · C 52
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Cochrane included 56 trials and 5,068 participants, with 51 trials suitable for meta-analysis. The beyond-three-month gingivitis estimate, SMD -0.21 (95% CI -0.31 to -0.12), came specifically from 16 trials and 1,645 participants, I-squared 51%, not from all 51 trials. Whether the roughly 11% index reduction was clinically important remained unclear.

02

Why this is classified as C (52)

Repeated positive findings are limited by a small long-term effect, unclear clinical importance, extensive manufacturer support, and few low-bias trials, giving C with 52 points.

Counterpoint. Timers, pressure sensors, and powered movement may still help people with technique or dexterity limitations.

Rejudgment record. Cross-check applied — Repeated statistical improvement in gingivitis indices, limited by a small long-term effect, unclear clinical importance, extensive manufacturer support, and heterogeneity

Scoring profile behind this grade
EndpointPPatient-reported treatment goal - the symptom is the goal
ReplicationR2Independently replicated across trials
IndependenceI1Mixed funding sources
Effect sizeE~Statistically positive but below the threshold

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Improved gingivitis indices at eight weeksCThe manufacturer trial succeeded but was short-term.
Reduced gingivitis beyond three monthsCSMD -0.21 was small and of unclear clinical importance.
Reduced gingival bleedingCFindings were repeatedly positive, but measures and products were heterogeneous.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Grender J et al. 2020Eight-week examiner-blinded randomized active-control trial110Conducted and supported by manufacturer Procter & Gamble; two authors were P&G employeesPrimary efficacy measures of MGI, GBI, and bleeding sitesAll succeeded with P<0.001; healthy gingiva in 82% versus 24%Short-term manufacturer direct trial
Yaacob M et al. 2014Cochrane systematic review and meta-analysis of randomized trials4,624Among included trials, 37 had manufacturer support, one a government scholarship, and 18 unclear fundingShort- and long-term gingivitis indicesBeyond-three-month gingivitis SMD -0.21 (95% CI -0.31 to -0.12), 16 trials and 1,645 participants, I-squared 51%; clinical importance unclearRepeated positive evidence with a small effect
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-07-24).

Grender J, Goyal CR, Qaqish J, Adam R. An 8-week randomized controlled trial comparing the effect of a novel oscillating-rotating toothbrush versus a manual toothbrush on plaque and gingivitis. Int Dent J. 2020;70(Suppl 1):S7-S15. PMID: 32243573. DOI: 10.1111/idj.12571.
checked
Yaacob M, Worthington HV, Deacon SA, et al. Powered versus manual toothbrushing for oral health. Cochrane Database Syst Rev. 2014;2014(6):CD002281. PMID: 24934383. DOI: 10.1002/14651858.CD002281.pub3.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-24 · Corrections: none

Cite this verdict

Powered toothbrush x gingivitis and gingival bleeding Evidence Grade C card
[Chamgap] Powered toothbrush x gingivitis and gingival bleeding — Evidence Grade C·52. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/general/powered-toothbrush-gingivitis-bleeding/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.